{"description":"All-treated analysis set which included all participants who received study intervention (cilta-cel out-of-specifications \\[OOS\\]).","eventGroups":[{"deathsNumAffected":16,"deathsNumAtRisk":82,"description":"Adult participants aged 18 years or older, with multiple myeloma received the lymphodepleting chemotherapy (cyclophosphamide 300 milligrams per meter square \\[mg/m\\^2\\] intravenous \\[IV\\] infusion and fludarabine 30 mg/m\\^2 IV infusion daily, for 3 days \\[Day -7 to Day -5\\]). After 5 to 7 days of initiating lymphodepleting chemotherapy, participants received IV infusion of cilta-cel OOS at a total targeted dose of 0.75\\*10\\^6 chimeric antigen receptor (CAR)-positive viable T-cells/kg (dose range 0.5\\*10\\^6 CAR-positive viable T cells/kg to 1.0\\*10\\^6 CAR-positive viable T cells/kg) based on participant's body weight at apheresis or per exceptional release criteria determined alternative dose.","id":"EG000","otherNumAffected":81,"otherNumAtRisk":82,"seriousNumAffected":42,"seriousNumAtRisk":82,"title":"Ciltacabtagene Autoleucel (Cilta-cel) Out-of-Specification (OOS)"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":49,"numAtRisk":82}],"term":"Anaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Febrile Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":44,"numAtRisk":82}],"term":"Leukopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":82}],"term":"Lymphopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":66,"numAtRisk":82}],"term":"Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":46,"numAtRisk":82}],"term":"Thrombocytopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Atrial Fibrillation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Sinus Bradycardia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":82}],"term":"Sinus Tachycardia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Dry Eye"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Vision Blurred"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Abdominal Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":82}],"term":"Constipation"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":82}],"term":"Diarrhoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":26,"numAtRisk":82}],"term":"Nausea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Stomatitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Vomiting"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":27,"numAtRisk":82}],"term":"Fatigue"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":82}],"term":"Oedema Peripheral"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":82}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Hyperbilirubinaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":47,"numAtRisk":82}],"term":"Cytokine Release Syndrome"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":82}],"term":"Hypogammaglobulinaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Covid-19"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Upper Respiratory Tract Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Urinary Tract Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Activated Partial Thromboplastin Time Prolonged"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":82}],"term":"Alanine Aminotransferase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":82}],"term":"Aspartate Aminotransferase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":82}],"term":"Blood Alkaline Phosphatase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":82}],"term":"Blood Creatinine Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Blood Fibrinogen Decreased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":82}],"term":"Blood Lactate Dehydrogenase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":82}],"term":"Gamma-Glutamyltransferase Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":82}],"term":"Decreased Appetite"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Hyperglycaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Hyperkalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Hyperphosphataemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":82}],"term":"Hypertriglyceridaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":82}],"term":"Hypoalbuminaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":82}],"term":"Hypocalcaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":82}],"term":"Hypokalaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":82}],"term":"Hypomagnesaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":17,"numAtRisk":82}],"term":"Hyponatraemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":82}],"term":"Hypophosphataemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":82}],"term":"Arthralgia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Back Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Muscular Weakness"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Pain in Extremity"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Dizziness"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":82}],"term":"Headache"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":82}],"term":"Immune Effector Cell-Associated Neurotoxicity Syndrome"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Paraesthesia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Tremor"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Confusional State"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":82}],"term":"Insomnia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":82}],"term":"Acute Kidney Injury"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":82}],"term":"Cough"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":82}],"term":"Dyspnoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":82}],"term":"Hypoxia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":82}],"term":"Nasal Congestion"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Oropharyngeal Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Pleural Effusion"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Rhinorrhoea"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Flushing"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":82}],"term":"Hypertension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":82}],"term":"Hypotension"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":82}],"term":"Orthostatic Hypotension"}],"seriousEvents":[{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Anaemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Febrile Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Leukopenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Neutropenia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Cardiac Arrest"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Adrenal Insufficiency"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":82}],"term":"Multiple Organ Dysfunction Syndrome"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":82}],"term":"Pyrexia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":19,"numAtRisk":82}],"term":"Cytokine Release Syndrome"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Adenovirus Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Clostridium Difficile Colitis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":82}],"term":"Covid-19"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Cytomegalovirus Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":82}],"term":"Pneumonia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":82}],"term":"Sepsis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Septic Embolus"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Septic Shock"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Streptococcal Bacteraemia"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":82}],"term":"Upper Respiratory Tract Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Urinary Tract Infection"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Liver Function Test Increased"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Neck Pain"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":82}],"term":"Bell's Palsy"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Cerebral Haemorrhage"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":82}],"term":"Haemorrhage Intracranial"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":82}],"term":"Immune Effector Cell-Associated Neurotoxicity Syndrome"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Neurotoxicity"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Seizure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Delirium"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Dysuria"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Renal Tubular Necrosis"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Urinary Retention"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Acute Respiratory Failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Pulmonary Embolism"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Respiratory Failure"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Haematoma"},{"assessmentType":"NON_SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA Version 26.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":82}],"term":"Hypotension"}],"timeFrame":"All-cause Mortality: From Day 1 (post infusion) up to 18.6 months; Serious and Other AEs: From Day 1 (post infusion) up to Day 100"}